| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $217.4M | $216.7M | $223.2M |
| YoY Revenue Growth % | +0.3% | -2.9% | — |
| Gross Profit | $86.6M | $90.3M | — |
| Gross Margin % | 39.9% | 41.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$154.2M | -$170.1M | -$135.4M |
| Operating Margin % | -70.9% | -78.5% | -60.7% |
| Net Income (GAAP) | -$150.7M | -$144.2M | -$128.8M |
| EBITDA (Normalized) | -$142.8M | -$158.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$57.1M | -$58.6M | -$104.4M |
| Capital Expenditures (CapEx) | $14.3M | $14.3M | — |
| Free Cash Flow (FCF) | -$71.4M | -$72.9M | -$104.4M |
| FCF Margin % | -32.9% | -33.7% | -46.8% |
| Return on Invested Capital (ROIC %) | -22.1% | -26.2% | — |
| Cash & Short-Term Equivalents | $145.5M | $274.2M | — |
| Total Debt (Short + Long Term) | $339.8M | $369.1M | — |
| Total Stockholders' Equity | $358.0M | $417.9M | — |